A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib Plus Trastuzumab Without Chemotherapy in HER2+ Breast Cancer.
CLINICAL CANCER RESEARCH（2023）
Key words
Breast Cancer,HER2,Metastatic Breast Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined